DNA sequencing is the process used to determine the sequence of nucleotides within a DNA molecule.Prenatal DNA sequencing is a method of sequencing DNA isolated from the blood of a pregnant woman to reveal the complete genetic code of the fetus.Prenatal DNA sequencing is used to sequence the entire genome of an unborn baby, effectively detecting diseases or conditions such as down syndrome, cystic fibrosis, thalassemia and cancer.
This report contains market size and forecasts of Prenatal DNA Sequencing in Global, including the following market information:
Global Prenatal DNA Sequencing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prenatal DNA Sequencing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Genetic Disorders Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prenatal DNA Sequencing include BGI, Agilent Technologies, Roche, Illumina, LabCorp, Natera and Twist Bioscience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prenatal DNA Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prenatal DNA Sequencing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prenatal DNA Sequencing Market Segment Percentages, by Type, 2021 (%)
Genetic Disorders
Nonhereditary Disease
Global Prenatal DNA Sequencing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prenatal DNA Sequencing Market Segment Percentages, by Application, 2021 (%)
Hemophilia
Down Syndrome
Cystic Fibrosis
Autism
DiGeorge Syndrome
AIDS
Cancer
Others
Global Prenatal DNA Sequencing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prenatal DNA Sequencing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prenatal DNA Sequencing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prenatal DNA Sequencing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BGI
Agilent Technologies
Roche
Illumina
LabCorp
Natera
Twist Bioscience